New diabetes clinical trial: Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation

Published on: November 25, 2024 at 11:00PM
Conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; Diabetes Mellitus; Impaired Fasting Glucose
Sponsors: Ruijin Hospital
Not yet recruiting
https://ift.tt/EwmjIVM